Yijia Group CORP 8-K filings

VitaNova Life Sciences Corporation announced the appointment of its Chief Financial Officer, Steve Niu, to its Board of Directors, effective February 19, 2026.

VitaNova Life Sciences Corporation announced the completion of its name change, 1-for-3 reverse stock split, and upcoming ticker symbol change to VNOV, effective for trading on the OTC Pink marketplace.

Yijia Group Corp. announced a corporate rebranding to VitaNova Life Sciences Corporation, a 1-for-3 reverse stock split, and the designation of Series A Preferred Stock.

Yijia Group Corp. announced plans for a corporate name change to VitaNova Life Sciences Corporation, a reverse stock split, and an increase in authorized capital, all approved by its Board and shareholders.

Yijia Group Corp. has replaced its independent registered public accounting firm, Olayinka Oyebola & Co., with Simon & Edward, LLP, effective June 5, 2024.

Yijia Group Corp. successfully completed a private offering of its common stock, raising $957,051 from ten investors.

Yijia Group Corp. has announced the resignation of its CFO, Qiuping Lu, and the appointment of Dr. Steve Niu as the new CFO, effective January 8, 2024.